Europe Wound Care Market (2024 - 2030)

Europe Wound Care Market Size & Trends

The Europe wound care market size was anticipated at USD 5.8 billion in 2023 and is expected to grow at a CAGR of 3.8% from 2024 to 2030. The growing prevalence of chronic diseases across the globe is one of the key factors fueling market growth. In addition, changing lifestyles, unhealthy eating habits, increasing consumption of alcohol, and rising new cases of non-communicable diseases (NCDs), such as cancer, diabetes, chronic respiratory disease, heart disease, and antimicrobial resistance, are supporting industry growth. Europe wound care market held a 26.2% share of the global wound care market revenue in 2023.

High disposable income levels, well-established & technologically advanced healthcare infrastructure, availability of skilled professionals, positive reimbursement coverages, rising cases of surgical site infections (SSIs) & chronic wounds, and increasing geriatric population in the region are also fueling market growth. Encouraging environment for innovative startups, innovation-backed new product launches, collaborations, mergers & acquisition strategies adopted by key companies for expansion and technology enhancements, partnerships, alliances & agreements for new product developments, and growing emphasis on R&D are other key factors expected to boost market growth.

Products Insights

The advanced wound dressing segment dominated the market and held the largest revenue share of 34.9% in 2023. These products are commonly used in the treatment of chronic and non-healing wounds. Some of the advanced wound dressing products are infused with antimicrobial agents, such as silver or honey, which can act as a catalyst in initiating rapid wound healing and work on preventing further infections. The limitations associated with traditional wound healing products and growing cases of chronic diseases, such as diabetes, are expected to support the segment's growth.

The surgical wound care segment is expected to register a CAGR of 4.0% from 2024 to 2030. This is primarily due to the growing prevalence of SSIs. In addition, a rising number of major surgeries performed yearly is expected to fuel segment growth. For instance, according to NCBI, around 310 million significant procedures are performed annually worldwide, of which 20 million are performed in Europe.

Application Insights

The chronic wounds segment dominated the market and accounted for a revenue share of 60.0% in 2023. One of the key factors driving the segment growth is the rising cases of chronic wounds in diabetic patients, such as foot ulcers. Increasing new cases of diabetes are adding to the situation. In addition, the prevalence of other chronic wounds, such as arterial, postsurgical, pressure, and venous stasis ulcers, is expected to fuel segment growth.

The acute wounds segment is expected to experience a CAGR of 3.9% from 2024 to 2030. This can be attributed to growing trauma cases in the region. These wounds include surgical & traumatic wounds and burn wounds. Treatment alternatives for acute wound care are advanced dressings, biologics, and traditional wound care products.

End-use Insights

The hospitals segment held the highest revenue share of 39.0% in 2023. Hospitals are equipped with resources and investments to adopt advanced wound care technologies and innovation-backed equipment. This, in turn, leads to optimized patient outcomes. Hospitals in Europe offer specialized dressings, deliver innovative therapies, and utilize advanced devices in wound care treatments.

The home healthcare segment is expected to experience a significant CAGR of 5.2% from 2024 to 2030. The anticipated growth can be attributed to various factors, such as a large pool of geriatric population, growing adoption of advanced wound care techniques in home healthcare, and rising incidences of diabetic foot ulcers, venous leg ulcers, & pressure ulcers.

Mode Of Purchase Insights

The prescribed mode of purchase segment dominated the industry and accounted for 62.7% share of the overall revenue in 2023. Wound care management is commonly monitored according to directions and instructions provided by experts, physicians, and surgeons. According to Public Health England, over 26% of the total adult population in the UK prefers prescription medications.

The segment is projected to expand further at a lucrative CAGR from 2024 to 2030. This is mainly due to the inclination to purchase prescribed wound care products owing to Medicare benefits that can only be available when a licensed healthcare practitioner prescribes the products.

Distribution Channel Insights

The institutional sales segment held the largest revenue share of 81.4% in 2023. The institutional distribution mainly comprises clinics, hospitals, dedicated wound care clinics, and other healthcare settings, such as long-term care facilities, diagnostic laboratories, nursing homes, and birth centers. The key companies engage in long-term contracts with these healthcare facilities to enhance their market penetration and sales every year.

The retail sales segment is expected to experience a CAGR of 4.2% from 2024 to 2030. This is primarily due to the easy accessibility to retail distribution points, such as pharmacy stores and e-commerce websites. Usually, customers without prescribed wound care treatment buy products from retail pharmacy stores for regular or emergency treatments. Online shopping for wound care products is preferred by customers needing quick home deliveries and easy accessibility.

Country Insights

UK Wound Care Market Trends

The UK wound care market dominated the regional market and accounted for a share of 17.1% in 2023. This can be attributed to factors including the rising number of diabetic patients suffering from foot injuries & other chronic wounds, the presence of several small- & mid-sized companies, constant new product launches, and expansion strategies adopted by key companies in the country in terms of manufacturing and distribution.

Spain Wound Care Market Trends

The wound care market in Spain is expected to register a CAGR of 4.2% from 2024 to 2030. This is primarily due to the growing expenditure on healthcare, increasing geriatric population, rising disposable income levels, and high prevalence of chronic diseases in the country. According to NCBI, more than 90% of the deaths in the country are caused by chronic diseases.

Key Europe Wound Care Company Insights

Some of the key and emerging companies in the market include Smith & Nephew PLC, Mölnlycke Health Care AB, ConvaTec Group PLC, Coloplast Corp., and Medtronic. Market players undertake several strategies to establish a competitive advantage over other players, such as collaborations, expansions, post-purchase assistance, innovation, and product differentiations.

• Medtronic is a medical devices company known for delivering solutions equipped with groundbreaking technologies for the most intricate and puzzling situations. The company operates in four key segments, namely, cardiac & vascular, minimally invasive therapies, diabetes, and restorative therapies. It has a global geographical reach and operates in nearly 150 countries. Some of its key customers include surgery centers, long-term care facilities, and home healthcare providers

• Smith & Nephew manufactures and distributes medical devices and services. The company provides sports medicine & ENT, orthopedics, and advanced wound care management services through distribution centers. The company’s products include instruments and implants, devices required for minimally invasive surgery, and products for the treatment of acute and chronic wounds, such as diabetic ulcers, postoperative wounds, and leg burns

Recent Developments

• In April 2024, Smith+Nephew, a global healthcare company in medical technology, launched the RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the U.S. market. The product is introduced as one of the patient-centric alternatives for treating chronic wounds. This system is designed with diligence and is empowered by a discreet canister that operates quietly without disturbing other patients

Europe Wound Care Market